Entero Healthcare Solutions Intrinsic Value
Entero Healthcare Solutions (ENTERO) median intrinsic value is ₹495.76 from 8 valuation models (range ₹372–₹1146), vs current price ₹1239.40 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit ENTERO stock price BSE.
ENTERO Valuation Methods Summary — DCF, Graham Number & P/E
Entero Healthcare Solutions intrinsic value across 8 models vs current price ₹1239.40 — upside/downside and value range per method. Browse Entero Healthcare Solutions annual reports for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹371.82 | ₹297.46 - ₹446.18 | -70.0% | EPS: ₹29.04, Sector P/E: 12x |
| Book Value Method | asset | ₹402.27 | ₹362.04 - ₹442.50 | -67.5% | Book Value/Share: ₹402.27, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1146.18 | ₹1031.56 - ₹1260.80 | -7.5% | Revenue/Share: ₹1432.73, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹495.76 | ₹446.18 - ₹545.34 | -60.0% | EBITDA: ₹268.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹371.82 | ₹334.64 - ₹409.00 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹371.82 | ₹334.64 - ₹409.00 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹619.70 | ₹557.73 - ₹681.67 | -50.0% | ROE: 8.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹512.68 | ₹461.41 - ₹563.95 | -58.6% | EPS: ₹29.04, BVPS: ₹402.27 |
ENTERO Intrinsic Value vs Market Price — All Valuation Models
Entero Healthcare Solutions fair value range ₹372–₹1146 vs current market price ₹1239.40 across 8 valuation models. Compare with ENTERO fair price to assess whether the stock is under or overvalued.
ENTERO Intrinsic Value Analysis — Undervalued or Overvalued?
Entero Healthcare Solutions median intrinsic value ₹495.76, current price ₹1239.40 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of ENTERO?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Entero Healthcare Solutions (ENTERO) is ₹495.76 (median value). With the current market price of ₹1239.40, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹371.82 to ₹1146.18, indicating ₹371.82 - ₹1146.18.
Is ENTERO undervalued or overvalued?
Based on our multi-method analysis, Entero Healthcare Solutions (ENTERO) appears to be trading above calculated value by approximately 60.0%.
ENTERO Financial Health — Key Ratios vs Industry Benchmarks
Entero Healthcare Solutions financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 23.86 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.33x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ENTERO Cash Flow Quality — Operating & Free Cash Flow
Entero Healthcare Solutions operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-77 Cr | ₹-77 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-37 Cr | ₹-389 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-45 Cr | ₹-70 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-35 Cr | ₹-116 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-69 Cr | ₹-85 Cr | Negative Cash Flow | 3/10 |